GLPHubglpresearchhub.com
Read-only archive. GLP Research Hub is a static community record — nothing here is for sale, no account is needed, and no vote you cast is counted. Why?
Single comment threadYou are looking at one branch of [Question] glucagon — what am I missing here — 13 comments in the full submission. View in context.
1.7k
c/survodutide·submitted 2 years ago by u/nora_ramos

[Question] glucagon — what am I missing here

Questionbranch of 4 comments

Been lurking in c/t2dglp1 for about 23 months and finally have something worth posting. Short version: week 57, 2.5mg, and hepatic fat is the bit I still cannot get a straight answer on. I have read the wiki, I have read the last 3 threads, and the answers split roughly down the middle. What I actually want to know…

Read the full submission and all 13 comments →

This branch

4 comments, started 2 years ago
u/elin_tamm156 points·2 years ago

Australia here. Waited 9 months on a list, gave up, went private, and the total cost was roughly what I expected.

replysharereportpermalink
u/camila_trevino47 points·2 years ago·edited

hepatic fat and survodutide are the story

replysharereportpermalink
u/valeria_karlsen118 points·2 years ago

Disagree but this is the good kind of wrong — it is specific enough to be checked.

replysharereportpermalink
u/joaquin_ivaturi209 points·2 years ago

Rodent data is rodent data. Dose scaling is not linear and the models tell you what to investigate, not what to expect.

replysharereportpermalink

← back to the whole thread

About c/survodutide

Survodutide-specific discussion: glucagon-receptor co-agonism, the hepatic fat and MASH resolution data, and how the side-effect profile compares with GIP-based dual agonism. Small community, high signal.

12kmembers
62submissions
Feb 2024created
submissions / month, last year
Sponsored

PeptideMeter Analytics

Independent testing plus vendor-level trend data. Community-funded, unaffiliated.

peptidemeter.com
c/survodutide rules
  1. Glucagon co-agonism has a distinct safety story. Do not generalise from tirzepatide.
  2. MASH claims need the trial and the biopsy endpoint.
  3. Not approved. Descriptive posts only.
  4. Independent community. Nobody here sells anything, and anyone who tries is banned.
  5. Not medical advice. Describe what you did; never prescribe to a stranger.
  6. Claims need evidence. Batch numbers, dated screenshots, independent test reports, or a citation.
  7. No referral links, discount codes or affiliate URLs. Permanent ban, no appeal.
  8. No contact handles, wallet addresses or tracking numbers — they identify people.
  9. Be recognisably decent. Disagree hard, insult nobody.
Moderators
Volunteers. Unpaid, unaffiliated, and reachable through modmail only.
Before you read on

Several compounds discussed on GLP Research Hub are sold for research use only and are not approved for human use anywhere. Nothing here is medical advice and none of it is written by your clinician. If a post reads like an instruction, treat it as a description of what one stranger did.